|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.705 USD | -2.57% |
|
-5.28% | +201.77% |
| 05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
| 05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
Nektar Therapeutics reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 21.64 million compared to USD 21.59 million a year ago. Net loss was USD 36.8 million compared to USD 137.02 million a year ago.
Basic loss per share from continuing operations was USD 0.19 compared to USD 0.73 a year ago. Diluted loss per share from continuing operations was USD 0.19 compared to USD 0.73 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +201.77% | 321M | |
| +40.21% | 723B | |
| +34.28% | 595B | |
| -3.70% | 369B | |
| +20.37% | 332B | |
| +2.92% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| +0.09% | 168B |
NEKTAR THERAPEUTICS 
